India's Alembic Pharma rises after US FDA approves herpesvirus drug
Today 07:30
BUZZ-India's Alembic Pharma rises after US FDA approves herpesvirus drug ** Shares of Alembic Pharmaceuticals ALEM.NS rise 2.4% to 785 rupees
** Drugmaker says US FDA has approved generic drug valganciclovir
** It is approved to treat cytomegalovirus (CMV) retinitis in patients with AIDS, and prevent CMV disease in kidney, heart, or kidney-pancreas transplant patients at high risk
** CMV is a lifelong virus belonging to the herpesvirus family
** YTD, stock down 7.2%
(Reporting by Puyaan Singh in Bengaluru)
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand